Patent · US Active

MTH1 inhibitors for treatment of cancer

US10179790B2 · kind B2 · utility

0Cited by

5References

46Claims

0Family size

Assignee

THOMAS HELLEDAYS STIFTELSE FÖR MEDICINSK FORSKNING · SE

Inventors

Martin Scobie · Uppsala, SE
Olov Wallner · Solna, SE
Tobias Koolmeister · Stockholm, SE
Karl Sven Axel Vallin · Stockholm, SE
Carl Martin Henriksson · Bromma, SE
Sylvain Jacques · Val-de-Reuil, FR
Evert Homan · Sollentuna, SE
Thomas Helleday · Stockholm, SE

Key dates

Filing date	Jun 4, 2015
Grant date	Jan 15, 2019
Priority date	—
Expiry date	Jun 4, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D491/048
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A compound of formula I, (I) or a pharmaceutically-acceptable salt thereof. The compound is useful in the treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.